Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 873Neoplasms, Plasma Cell 162Lymphoma, Non-Hodgkin 139Lymphoma 135Hodgkin Disease 134Leukemia, Lymphocytic, Chronic, B-Cell 118Precursor Cell Lymphoblastic Leukemia-Lymphoma 109Myelodysplastic Syndromes 103Recurrence 101Leukemia, Myeloid, Acute 99Leukemia 94Lymphoma, Mantle-Cell 80Lymphoma, Large B-Cell, Diffuse 76Lymphoma, Follicular 73Myeloproliferative Disorders 69Lymphoma, B-Cell, Marginal Zone 69Hematologic Neoplasms 64Burkitt Lymphoma 64Primary Myelofibrosis 57Lymphoma, Large-Cell, Immunoblastic 55Waldenstrom Macroglobulinemia 52Leukemia, Myelogenous, Chronic, BCR-ABL Positive 52Leukemia, Myeloid, Chronic-Phase 46Lymphoma, T-Cell, Cutaneous 44Immunoglobulin Light-chain Amyloidosis 43Congenital Abnormalities 43Neoplasms 41Leukemia, Myelomonocytic, Chronic 41Leukemia, Myeloid, Accelerated Phase 40Sezary Syndrome 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Chronobiology Disorders × Plasma cell × Clear all
NCT03198754 2020-08-11

PEI

Icahn School of Medicine at Mount Sinai

Phase NA Completed
73 enrolled 20 charts
Plasma cell

Depression, Multiple Myeloma, Neoplasms, Chronobiology Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡